Mallinckrodt has never grown the biz







Because their portfolio sucks! It will be the same for the latest acquisition. I wonder what the reimbursement for ECP will look like next year, went down from 2014 to 2015.
 






Because their portfolio sucks! It will be the same for the latest acquisition. I wonder what the reimbursement for ECP will look like next year, went down from 2014 to 2015.

Don't blame it on the entire portfolio. I hate this company, but Ofirmev is a great drug. Mallinckrodt is what destroyed that business and any sales rep that has been able to keep their business volume should be rewarded despite Mallinckrodt executives fucking up everything. This clearly isn't happening either and will result in Mallinckrodt losing their top reps. The people bring in the volume and money should be the ones rewarded and they simply just don't get that. Stupid.